Guardant Health
$3.48 B
Share price
Change (1 day)
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Cash on Hand

Cash on Hand as of June 2023 : $1.22 B

According to Guardant Health 's latest financial reports the company has $1.22 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Guardant Health - Cash on Hand chart (from 2017 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31$1.01 B8.41%
2021-12-31$0.93 B-48.03%
2020-12-31$1.79 B243.32%
2019-12-31$0.52 B24.79%
2018-12-31$0.41 B89.3%
2017-12-31$0.22 B132.34%
2016-12-31$95.25 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.24 B-79.95%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.73 B-39.92%๐Ÿ‡บ๐Ÿ‡ธ USA